Your browser doesn't support javascript.
loading
Wilms' tumor blastemal stem cells dedifferentiate to propagate the tumor bulk.
Shukrun, Rachel; Pode-Shakked, Naomi; Pleniceanu, Oren; Omer, Dorit; Vax, Einav; Peer, Eyal; Pri-Chen, Sara; Jacob, Jasmine; Hu, Qianghua; Harari-Steinberg, Orit; Huff, Vicki; Dekel, Benjamin.
Afiliação
  • Shukrun R; Pediatric Stem Cell Research Institute, Sheba Medical Center, Tel Hashomer 5262000, Israel ; Sheba Centers for Regenerative Medicine and Cancer Research, Sheba Medical Center, Ramat-Gan, Tel Hashomer 5262000, Israel ; Sackler School of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.
  • Pode-Shakked N; Pediatric Stem Cell Research Institute, Sheba Medical Center, Tel Hashomer 5262000, Israel ; Sheba Centers for Regenerative Medicine and Cancer Research, Sheba Medical Center, Ramat-Gan, Tel Hashomer 5262000, Israel ; Dr. Pinchas Borenstein Talpiot Medical Leadership Program 2013, Sheba Medical Cent
  • Pleniceanu O; Pediatric Stem Cell Research Institute, Sheba Medical Center, Tel Hashomer 5262000, Israel ; Sheba Centers for Regenerative Medicine and Cancer Research, Sheba Medical Center, Ramat-Gan, Tel Hashomer 5262000, Israel ; Sackler School of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.
  • Omer D; Pediatric Stem Cell Research Institute, Sheba Medical Center, Tel Hashomer 5262000, Israel ; Sheba Centers for Regenerative Medicine and Cancer Research, Sheba Medical Center, Ramat-Gan, Tel Hashomer 5262000, Israel ; Sackler School of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.
  • Vax E; Pediatric Stem Cell Research Institute, Sheba Medical Center, Tel Hashomer 5262000, Israel ; Sheba Centers for Regenerative Medicine and Cancer Research, Sheba Medical Center, Ramat-Gan, Tel Hashomer 5262000, Israel ; Sackler School of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.
  • Peer E; Sheba Centers for Regenerative Medicine and Cancer Research, Sheba Medical Center, Ramat-Gan, Tel Hashomer 5262000, Israel ; Sackler School of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.
  • Pri-Chen S; The Maurice and Gabriela Goldschleger Eye Research Institute, Sheba Medical Center, Tel Hashomer 5262000, Israel.
  • Jacob J; Sheba Centers for Regenerative Medicine and Cancer Research, Sheba Medical Center, Ramat-Gan, Tel Hashomer 5262000, Israel.
  • Hu Q; Department of Genetics, MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Harari-Steinberg O; Pediatric Stem Cell Research Institute, Sheba Medical Center, Tel Hashomer 5262000, Israel ; Sheba Centers for Regenerative Medicine and Cancer Research, Sheba Medical Center, Ramat-Gan, Tel Hashomer 5262000, Israel.
  • Huff V; Department of Genetics, MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Dekel B; Pediatric Stem Cell Research Institute, Sheba Medical Center, Tel Hashomer 5262000, Israel ; Sheba Centers for Regenerative Medicine and Cancer Research, Sheba Medical Center, Ramat-Gan, Tel Hashomer 5262000, Israel ; The Maurice and Gabriela Goldschleger Eye Research Institute, Sheba Medical Center
Stem Cell Reports ; 3(1): 24-33, 2014 Jul 08.
Article em En | MEDLINE | ID: mdl-25068119
ABSTRACT
An open question remains in cancer stem cell (CSC) biology whether CSCs are by definition at the top of the differentiation hierarchy of the tumor. Wilms' tumor (WT), composed of blastema and differentiated renal elements resembling the nephrogenic zone of the developing kidney, is a valuable model for studying this question because early kidney differentiation is well characterized. WT neural cell adhesion molecule 1-positive (NCAM1(+)) aldehyde dehydrogenase 1-positive (ALDH1(+)) CSCs have been recently isolated and shown to harbor early renal progenitor traits. Herein, by generating pure blastema WT xenografts, composed solely of cells expressing the renal developmental markers SIX2 and NCAM1, we surprisingly show that sorted ALDH1(+) WT CSCs do not correspond to earliest renal stem cells. Rather, gene expression and proteomic comparative analyses disclose a cell type skewed more toward epithelial differentiation than the bulk of the blastema. Thus, WT CSCs are likely to dedifferentiate to propagate WT blastema.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Células-Tronco Neoplásicas / Tumor de Wilms Limite: Animals / Female / Humans Idioma: En Revista: Stem Cell Reports Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Israel

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Células-Tronco Neoplásicas / Tumor de Wilms Limite: Animals / Female / Humans Idioma: En Revista: Stem Cell Reports Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Israel